MDMA does not alter responses to the Trier Social Stress Test in humans
±3,4-Methylenedioxymethamphetamine (MDMA, “ecstasy”) is a stimulant-psychedelic drug with unique social effects. It may dampen reactivity to negative social stimuli such as social threat and rejection. Perhaps because of these effects, MDMA has shown promise as a treatment for post-traumatic stress disorder (PTSD). However, the effect of single doses of MDMA on responses to an acute psychosocial stressor has not been tested.
In this study, we sought to test the effects of MDMA on responses to stress in healthy adults using a public speaking task. We hypothesized that the drug would reduce responses to the stressful task.
Volunteers (N = 39) were randomly assigned to receive placebo (N = 13), 0.5 mg/kg MDMA (N = 13), or 1.0 mg/kg MDMA (N = 13) during a stress and a no-stress session. Dependent measures included subjective reports of drug effects and emotional responses to the task, as well as salivary cortisol, heart rate, and blood pressure.
The stress task produced its expected increase in physiological responses (cortisol, heart rate) and subjective ratings of stress in all three groups, and MDMA produced its expected subjective and physiological effects. MDMA alone increased ratings of subjective stress, heart rate, and saliva cortisol concentrations, but contrary to our hypothesis, it did not moderate responses to the Trier Social Stress Test.
Despite its efficacy in PTSD and anxiety, MDMA did not reduce either the subjective or objective responses to stress in this controlled study. The conditions under which MDMA relieves responses to negative events or memories remain to be determined.
KeywordsMDMA Stress Trier Social Stress Test Anxiety Cortisol
- Baggott MJ, Coyle JR, Siegrist JD, Garrison KJ, Galloway GP, Mendelson JE (2015) Effects of MDMA on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting. doi:10.1101/021329
- Gerra G, Bassignana S, Zaimovic A, Moi G, Bussandri M, Caccavari R, Brambilla F, Molina E (2003) Hypothalamic–pituitary–adrenal axis responses to stress in subjects with 3, 4-methylenedioxy-methamphetamine (‘ecstasy’) use history: correlation with dopamine receptor sensitivity. Psychiatry Res 120:115–124CrossRefPubMedGoogle Scholar
- Hysek CM, Schmid Y, Simmler LD, Domes G, Heinrichs M, Eisenegger C, Preller KH, Quednow BB, Liechti ME (2013) MDMA enhances emotional empathy and prosocial behavior. Soc Cogn Affect Neurosci 9:1645Google Scholar
- Kudielka BM, Hellhammer DH, Kirschbaum C, Harmon-Jones E, Winkielman P (2007) Ten years of research with the Trier social stress test—revisited. Social neuroscience: Integrating biological and psychological explanations of social behavior:56–83Google Scholar
- Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Doblin R (2011) The safety and efficacy of±3, 4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. J Psychopharmacol 25:439–452CrossRefPubMedPubMedCentralGoogle Scholar
- Mithoefer M, Wagner M, Mithoefer A, Jerome L, Martin S, Yazar-Klosinski B (2013) Durability of improvement in PTSD symptoms and absence of harmful effects or drug dependency after MDMA-assisted psychotherapy: a prospective long-term follow-up study. J Psychopharmacol 27:28–39CrossRefPubMedPubMedCentralGoogle Scholar
- Wardle MC, de Wit H (2014) MDMA alters emotional processing and facilitates positive social interaction. Psychopharmacology 231:4219–4229Google Scholar